reviewTop 1% cited
Alzheimer's disease: Recent treatment strategies
European Journal of Pharmacology · 2020 · Vol. 887 · pp. 173554–173554
Miguel Vaz(University of Beira Interior)Samuel Silvestre✉(University of Beira Interior)
Alzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesComputational Drug Discovery MethodsRivastigmineDonepezilGalantamineMemantineClinical trialDiseaseMedicineTau proteinAlzheimer's diseaseDementia
MeSH terms
Alzheimer DiseaseAnimalsAntibodies, MonoclonalHumansImmunotherapyAmyloid beta-Peptidestau ProteinsTauopathies
Funding
- Fundação para a Ciência e a Tecnologia
Citations
515
FWCI
37.45
field-weighted impact
References
188
Percentile
100%
vs. same field & year
Citations per year
Cited by
PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer’s Disease and Parkinson’s Disease
Frontiers in Pharmacology · 2021 · 467 citations
References
Memantine for dementia
Cochrane Database of Systematic Reviews · 2006 · 1,019 citations
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
Neurology · 2003 · 1,336 citations
Tau in physiology and pathology
Nature reviews. Neuroscience · 2015 · 2,133 citations
Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
Science Translational Medicine · 2016 · 732 citations
Dementia prevention, intervention, and care
The Lancet · 2017 · 6,106 citations
Microglia in Alzheimer’s disease
The Journal of Cell Biology · 2017 · 1,898 citations
Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
Frontiers in Neuroscience · 2018 · 820 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.